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Abstract
G protein-coupled receptors (GPCRs) self-associate as dimers or higher-order oligomers in living cells. The stability of
associated GPCRs has not been extensively studied, but it is generally thought that these receptors move between the
plasma membrane and intracellular compartments as intact dimers or oligomers. Here we show that b2-adrenergic
receptors (b2ARs) that self-associate at the plasma membrane can dissociate during agonist-induced internalization. We use
bioluminescence-resonance energy transfer (BRET) to monitor movement of b2ARs between subcellular compartments.
BRET between b2ARs and plasma membrane markers decreases in response to agonist activation, while at the same time
BRET between b2ARs and endosome markers increases. Energy transfer between b2ARs is decreased in a similar manner if
either the donor- or acceptor-labeled receptor is mutated to impair agonist binding and internalization. These changes take
place over the course of 30 minutes, persist after agonist is removed, and are sensitive to several inhibitors of arrestin- and
clathrin-mediated endocytosis. The magnitude of the decrease in BRET between donor- and acceptor-labeled b2ARs
suggests that at least half of the receptors that contribute to the BRET signal are physically segregated by internalization.
These results are consistent with the possibility that b2ARs associate transiently with each other in the plasma membrane, or
that b2AR dimers or oligomers are actively disrupted during internalization.
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Introduction
Abundant evidence suggests that G protein-coupled receptors
(GPCRs) can self-associate as dimers or higher-order oligomers.
Although signaling to heterotrimeric G proteins and arrestins does
not require self-association [1,2,3], several functional interactions
between receptors have been attributed to oligomerization. Among
the processes thought to be influenced by oligomerization are
trafficking of GPCRs to the plasma membrane during biosynthesis,
and internalization following ligand activation [4]. Several studies
have shown that receptors that fail to reach the plasma membrane
during biosynthesis can exert a dominant negative effect that leads
to intracellular retention of other receptors [4,5]. In other cases
forward trafficking of poorly-expressed receptors is facilitated by
expression of other GPCRs [6]. Similarly, in several instances
agonist-induced internalizationof a given GPCR has beenshown to
promote internalization of either a disabled mutant or a different
GPCR altogether [7,8,9,10,11]. These observations have led to the
general conclusion that GPCRs traffic to and from the plasma
membrane as intact homo- and heterooligomers.
This conclusion is consistent with the concept that GPCRs
associate with each other as thermodynamically stable dimers and
higher-order oligomers. However, it has recently been suggested
that several GPCRs self-associate transiently on the cell surface
[12,13,14], raising the possibility that such GPCRs might not
traffic as intact dimers or oligomers. This possibility prompted us
to investigate the self-association of b2-adrenergic receptors
(b2ARs) during agonist-induced internalization, as these receptors
are prototypical for both oligomerization [15] and agonist-induced
internalization [16]. Here we show that agonist-induced internal-
ization segregates active and inactive b2ARs that are initially in
close proximity at the plasma membrane. This result is consistent
with the possibility that b2AR dimers or oligomers are not
completely stable on the cell surface.
Results
BRET reports b2AR internalization
In order to study b2AR self-association and internalization
together in intact cells we used an assay in which resonance energy
transfer between receptors and an inert plasma membrane marker
is measured with and without agonist application [17]. In this
application BRET is used not to indicate a protein-protein
interaction, but rather as an indicator of subcellular location. The
Renilla luciferase Rluc8 was fused to the C-terminus of the b2AR
(b2AR-Rluc8) to serve as a BRET donor. The fluorescent protein
venus was fused to the N-terminus of a C-terminal fragment of
KRas (V-kras) to serve as a plasma membrane-associated BRET
acceptor. Transient expression of these two proteins in HEK 293
cells produced a substantial BRET signal, as expected for two
proteins that are associated with the plasma membrane. Activation
of b2AR-Rluc8 by pretreating with isoproterenol (10 mM) for 30
minutes induced a significant decrease in BRET compared to
vehicle-treated controls, consistent with the removal of a fraction
of these receptors from the plasma membrane (Figure 1A, C) [16].
Net BRET between b2AR-Rluc8 and V-kras was 0.2660.02 in
control cells and 0.1560.02 in isoproterenol-treated cells (DBRET
= -0.1160.01, n=5, performed in quadruplicate; Table S1).
BRET measurements were made immediately after cells were
washed and harvested in agonist-free buffer, thus the decrease in
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b2AR-Rluc8. This decrease was prevented if the antagonist
propranolol (10 mM) was applied at the same time as isoproter-
enol, and was partially reversed if isoproterenol was removed for
30 minutes prior to harvesting cells and measuring BRET
(Figure 1C). In addition, no significant isoproterenol-induced
BRET change was observed when b2AR-Rluc was mutated
(D113S) [18] to prevent high-affinity isoproterenol binding
(Figure 1C). The isoproterenol-induced BRET decrease was
concentration-dependent, with an EC50 of 75 nM (Figure 1D).
Several observations suggested that the isoproterenol-induced
decrease in BRET between b2AR-Rluc8 and V-kras was due to
arrestin- and dynamin-dependent internalization of b2AR-Rluc8.
For example, we found that isoproterenol produced a reciprocal
increase in BRET between b2AR-Rluc8 and venus-labeled rab5a
(V-rab5; Figure 1A, C), which is associated with early endosomes
(Figure 1B) and clathrin-coated pits [19]. In addition, the
isoproterenol-induced BRET decrease developed over the course
of 30 minutes, and persisted when intact cells were washed and then
exposed to the antagonist propranolol (Figure 1E). These features
are consistent with previous studies of b2AR internalization [16,17],
and are not consistent with the change in BRET ratio simply being
due to a change in relative distance/orientation of the donor and
acceptor on the cell surface. To test this conclusion further we
employed several methods that are known to inhibit clathrin-
mediated endocytosis. The isoproterenol-induced decrease in
BRET between b2AR-Rluc8 and V-kras was significantly inhibited
by pretreatment with hypertonic sucrose (Figure 2A), preincubation
of cells at 4uC (Figure 2B), coexpression of dominant-negative
arrestin2 (319-418) [20] (Figure 2C), coexpression of dominant-
negative dynamin K44A [21] (Figure 2D), and pretreatment with
the small molecule dynamin inhibitor dynasore (80 mM) [22]
(Figure 2E). In terms of efficacy, sucrose and 4uC incubation were
the most effective inhibitors of the BRET decrease, arrestin2 (319–
418) and dynasore were the least effective, and dynamin K44A was
intermediate. In some cases (e.g. with expression of arrestin2 (319–
418)) these treatments changed net BRET in control cells not
exposed to isoproterenol (Table S2). These results indicate that
BRET, like FRET [17], is a sensitive reporter of agonist-induced
b2AR internalization in living cells.
Interactions between active and inactive b2ARs during
internalization
We next used BRET to look for interactions between b2ARs
during internalization. Specfically, we wanted to know if inactive
b2ARs could impede internalization of active b2ARs, or alterna-
tively if active b2ARs could promote internalization of inactive
b2ARs [7,8,10,11]. Wild-type (wt) b2AR-Rluc8 was coexpressed
with V-kras and either the unlabeled binding-defective mutant
b2AR D113S [18] or unlabeled wild-type b2AR. In both cases a
five-fold excess of plasmid DNA expressing the unlabeled receptor
was transfected in order to maximize the likelihood that Rluc8-
labeled receptors would associate with unlabeled receptors. The
presence of binding-defective b2AR D113S did not impede
internalization of b2AR-Rluc8 as determined by the isoprotere-
nol-induced decrease in BRET (Figure 3A). In fact, internalization
was significantly greater with coexpression of b2AR D113S than
with coexpression of b2AR (P,0.05, repeated measures ANOVA).
The underlying cause of this difference is not clear, but it may
reflect competition between b2AR-Rluc8 and b2AR for limited
internalization capacity. Alternatively, this difference may reflect
negative allosteric interactions between active receptor protomers,
as has been described for other GPCRs [23]. Not surprisingly, no
isoproterenol-induced internalization was detected when both
Rluc8-labeled and unlabeled b2ARs were binding-defective D113S
mutants. In contrast, modest but significant internalization of
b2AR D113S-Rluc8 was detected when wt b2AR was present
Figure 1. BRET reports b2AR internalization. A,s c h e m a t i c
representation of the location and orientation of b2AR-Rluc8, the
plasma membrane acceptor venus-kras (V-kras), and the early
endosome acceptor venus-rab5 (V-rab5). B, confocal images of cells
expressing cerulean-kras (C-kras) and V-rab5; the kras and rab5
localization signals direct fluorescent proteins to distinct compartments
consistent with the plasma membrane and early endosomes, respec-
tively. Scale bar =20 mm. C, changes in BRET (DBRET) between b2AR-
Rluc8 and V-kras (left) and V-rab5 (right) after 30 minute incubation with
10 mM isoproterenol, isoproterenol plus 10 mM propranolol, 30 minutes
after isoproterenol removal (wash), or after isoproterenol with b2AR
D113S-Rluc8 (n=4 experiments performed in quadruplicate); *, P,0.05;
**, P,0.005, paired t-test, meaning the isoproterenol-induced DBRET is
significantly different from zero. Values of net BRET are given in Table
S1. D, changes in BRET between b2AR-Rluc8 and V-kras as a function of
isoproterenol concentration. The smooth line is a least-squares fit to a
Hill equation (EC50=75 nM; n=4). E, net BRET between b2AR-Rluc8 and
V-kras as a function of time after addition of isoproterenol; BRET was
measured after isoproterenol was removed and replaced with 10 mm M
propranolol. The smooth line is a least-squares fit to a single exponent
(t=13.3 minutes; n=4).
doi:10.1371/journal.pone.0017361.g001
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BRET between b2AR-Rluc8 and V-kras, 44%63% of the signal
was lost after internalization if b2AR-Rluc8 was active and
unlabeled b2AR was inactive, whereas only 6%61% of the signal
was lost if b2AR-Rluc8 was inactive and unlabeled b2AR was
active. This result is consistent with previous reports where wild-
type GPCRs promoted the agonist-induced internalization of
binding- or internalization-defective receptors [7,8,9,10,11]. How-
ever, our quantitative results suggest that the efficiency of this
process is low.
The weak influence of wild-type b2AR on internalization of
b2AR D113S-Rluc8 prompted us repeat the same basic experi-
ment using a more conventional method of detecting internaliza-
tion. Accordingly, Rluc8-labeled receptors were replaced with N-
terminally Flag-tagged receptors (Flag-b2AR), and internalization
was measured by assaying loss of cell-surface Flag immunoreac-
tivity by ELISA. The results of this experiment agreed well with
our BRET results (Figure 3B), with the exception that this assay
failed to detect significant agonist-induced internalization of Flag-
b2AR D113S in the presence of b2AR.
Finally, we combined the two detection methods by expressing
Rluc8-labeled receptors and Flag-tagged receptors together (with
Figure 2. Isoproterenol-induced changes in BRET are sensitive
to inhibitors of clathrin-mediated endocytosis. A–E, the percent
change in net BRET induced by isoproterenol is plotted for cells
expressing b2AR-Rluc8 and V-kras (left)o rb2AR-Rluc8 and b2AR D113S-V
(right). Cells were pretreated with vehicle or were cotransfected with
vector (control), or were pretreated with 400 mM sucrose (A; n=5 and
5), incubated at 4uC( B; n=5 and 6), cotransfected with arrestin2 (319–
418) (C; n=6 and 6), cotransfected with dynamin K44A (D; n=5 and 5),
or pretreated with dynasore (80 mM; E; n=4 and 4); **, P,0.005, paired
t-test, meaning the percent change in net BRET in the presence of
sucrose, etc., is significantly different from the control percent change
in net BRET. Values of net BRET are given in Table S2 and Table S4.
doi:10.1371/journal.pone.0017361.g002
Figure 3. Interactions between active and inactive (binding-
defective) b2ARs during internalization. A, decreases in BRET
(DBRET) after isoproterenol treatment in cells expressing two different
b2ARs. Either wild-type (wt) or binding-defective (D113S) b2AR-Rluc8
were expressed with either wt or D113S unlabeled b2AR and V-kras
(n=4). Modest but significant internalization of b2AR D113S-Rluc8 is
promoted by unlabeled wt b2AR. B, loss of cell surface Flag
immunoreactivity in cells expressing either wild-type (wt) or binding-
defective (D113S) Flag-b2AR together with either wt or D113S
unlabeled b2AR (n=4). No detectable internalization of Flag-b2AR
D113S was promoted by unlabeled wt b2AR. C, decreases in BRET (left)
and loss of cell surface Flag immunoreactivity (right) after isoproterenol
treatment in cells expressing the indicated combinations of b2AR-Rluc8
and Flag-b2AR (n=4–5). *, P,0.05; **, P,0.005, paired t-test, meaning
DBRET or % internalization is significantly different from zero. Values of
net BRET are given in Table S3.
doi:10.1371/journal.pone.0017361.g003
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b2ARs internalized in response to agonist while at the same time
binding-defective b2ARs largely remained on the cell surface using
two independent methods. Accordingly, BRET signals decreased
significantly in response to isoproterenol when Rluc8-labeled
receptors were wild-type, but far less or not at all if Rluc8-labeled
receptors were binding-defective (Figure 3C). Cell surface Flag
immunoreactivity decreased significantly only when Flag-tagged
receptors were binding-competent (Figure 3C).
Internalization segregates active and inactive b2ARs
In light of the evidence that b2ARs self-associate in the plasma
membrane, our results indicating only modest functional interac-
tions between wild-type and binding-defective b2ARs during
internalization suggested that some active and inactive receptors
segregate during this process. However, in these experiments it
was not possible to directly verify the expectation that wild-type
and binding-defective b2ARs associated with each other in dimers
or higher order oligomers. Therefore, to test the idea of protomer
segregation more directly we measured changes in BRET between
b2AR-Rluc8 and the venus-labeled acceptor b2AR-V (and binding
defective mutants of these receptors) due to stimulation with
isoproterenol (Figure 4A).
Substantial BRET was observed when b2AR-Rluc8 and b2AR-
V were coexpressed, as has been reported previously [24]. Basal
net BRET (without isoproterenol treatment) between wild-type
b2AR-Rluc8 and wild-type b2AR-V (0.2060.02; n=27) and that
between wild-type b2AR-Rluc8 and b2AR D113S-V (0.1860.01;
n=26; P=0.19, unpaired t-test) were not significantly different,
suggesting that the D113S mutation did not interfere with b2AR
maturation or association [11,18]. When the donor was wild-type
b2AR-Rluc8 and the acceptor was binding-defective b2AR
D113S-V, isoproterenol reliably induced a significant BRET
decrease (to 0.1560.01; P,0.001, paired t-test). As was the case
with the plasma membrane-associated acceptor V-kras, the
agonist-induced decrease in BRET between b2AR-Rluc8 and
b2AR D113S-V developed over the course of 30 minutes
(Figure 4B; cf. Figure 1E), and persisted when cells were washed
with and exposed to the antagonist propranolol. As was the case
with the V-kras, all five methods of inhibiting clathrin-mediated
endocytosis significantly inhibited the agonist-induced decrease in
BRET to b2AR D113S-V, and in each case the degree of
inhibition was similar to what was observed when the donor was
V-kras (Figure 2A–E; Table S4). Susceptibility to these manipu-
lations indicates that this agonist-induced BRET change is largely
due to arrestin- and dynamin-dependent processes, as opposed to
conformational changes within or between associated b2ARs.
Similar results were obtained when the donor was binding-
defective b2AR D113S-Rluc8 and the acceptor was wild-type
b2AR-V (DS/wt in Figure S1), but not when both donor and
acceptor were binding defective (b2AR D113S-Rluc8 and b2AR
D113S-V; DS/DS in Figure S1). Taken together these results are
consistent with a model wherein active wild-type b2AR internal-
izes in response to agonist, while inactive b2AR D113S remains in
the plasma membrane (Figure 4A).
Interestingly, when both b2AR-Rluc8 and b2AR-V were wild-
type isoproterenol reliably induced a significant increase in BRET
(to 0.2260.02; P,0.0001, paired t-test; wt/wt in Figure S1), as
reported previously [24]. One possible explanation for this is that
both donor- and acceptor-labeled receptors were concentrated in
clathrin-coated pits and vesicles, as the BRET increase was
significantly reduced by manipulations known to inhibit clathrin
assembly and by dynamin K44A (Figure S1). Surprisingly, the
dynamin inhibitor dynasore enhanced the agonist-induced BRET
increase between wild-type b2ARs. The reason for the difference
between the effects of dynamin K44A and dynasore on agonist-
induced BRET between wild-type b2ARs is not obvious. However,
these two agents are known to act at different stages of clathrin-
coated pit formation [22,25], thus it is possible that dynasore traps
receptors in newly-formed coated pits, whereas dynamin K44A
prevents recruitment to coated pits altogether.
BRET signals between b2AR-Rluc8 and b2AR-V could arise
from specific association of individual protomers to form dimers,
specific association of dimers to form higher-order oligomers, or
non-specific colocalization of any of these elements. Internaliza-
tion of active receptors could conceivably disrupt any or all of
these modes of association. We considered the possibility that
internalization disrupted only non-specific colocalization of b2ARs
by measuring BRET between b2AR-Rluc8 and b2AR D113S-V
across a range of acceptor/donor ratios, as removal of a non-
specific component would be predicted to lead to saturation of
BRET at a lower acceptor/donor ratio [26]. As shown previously
[27], net BRET increased hyperbolically as the relative expression
of b2AR D113S-V increased for both control and isoproterenol-
treated cells (Figure 4C). The acceptor/donor ratio at which
BRET was half-maximum (BRET50) was 0.15 arbitrary units for
both groups of cells, thus the isoproterenol-induced BRET
decrease did not depend on the acceptor/donor ratio. This result
suggests that the agonist-induced decrease in BRET between
b2AR-Rluc8 and b2AR D113S-V was not due to the selective
Figure 4. Internalization segregates active and inactive b2ARs.
A, schematic representation of recruitment of wild-type (wt) b2AR-Rluc8
and wt b2AR-V to coated pits and internalization (left), and segregation
of wt b2AR-Rluc8 and b2AR D113S-V (right). B, net BRET between wt
b2AR-Rluc8 and b2AR D113S-V as a function of time after addition of
isoproterenol; BRET was measured after isoproterenol was removed and
replaced with 10 mM propranolol. The smooth line is a least-squares fit
to a single exponent (t=13.3 minutes; n=4). C, net BRET between wt
b2AR-Rluc8 and b2AR D113S-V with increasing expression of the
acceptor in control and isoproterenol-treated cells. Smooth curves are
least-squares fits to a hyperbolic function; the derived V/Rluc8 intensity
ratio at which net BRET was half-maximal (BRET50) was 0.15 in both
cases, thus the agonist-induced decrease BRET decrease did not
depend on V/Rluc8.
doi:10.1371/journal.pone.0017361.g004
Internalization Dissociates Adrenergic Receptors
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17361elimination of a non-specific signal, and that the average affinity of
b2AR association was the same in agonist-treated and control cells.
Discussion
The results of this study suggest that the association of b2ARs is
not permanent in living cells, and that active and inactive b2ARs
that are associated at the cell surface dissociate during agonist-
induced internalization of active protomers.
Most previous studies have concluded that GPCRs internalize
in response to agonist as intact dimers, even when only one
protomer binds ligand [7,8,10,11]. For example, studies in the
yeast Saccharomyces cervisiae have reported that internalization of
wild-type Ste2 receptors promoted internalization of internaliza-
tion- or binding-defective receptors [7], although this process was
less efficient than expected for completely stable dimers [10].
Similarly, internalization of opioid receptors can promote
internalization of other opioid receptors or b2ARs, and internal-
ization of b2ARs can promote internalization of opioid receptors
[28,29]. These studies support the general conclusion that GPCRs
internalize as intact hetero- and homodimers or oligomers after
activation of a single protomer [4]. However, in other cases
activation of one protomer either fails to induce internalization of
heterodimers (e.g. d-k opioid heterodimers) [30], or promotes
dissociation of heterodimers (e.g. endothelin A-endothelin B
heterodimers) [31].
In the present study we provide direct evidence that a
substantial fraction of the interactions that contribute to energy
transfer between active and inactive b2ARs in intact cells is
disrupted by internalization. Our results appear to be at odds with
those of Sartania et al. [11], who concluded that b2ARs internalize
as intact homodimers. However, this study did not quantitate the
fraction of b2ARs that internalize as dimers, and did not rule out
disruption of a fraction of b2AR assemblies. Our results are also
somewhat surprising in light of reports which have shown that
b2ARs with altered trafficking itineraries can efficiently impede the
cell surface expression and recycling of wild-type b2ARs [5,32].
Taken together these studies suggest that the interaction between
receptor trafficking and oligomerization may differ for the various
receptors and for various stages of the receptor life cycle.
What fraction of interactions between b2ARs is disrupted by
internalization? Previous studies using methods similar to those
used here have shown that, at steady-state, agonist-induced
internalization decreases the number of b2ARs in the plasma
membrane by about one-half to two-thirds [16,33]. We observed a
similar decrease in the present study using a cell-surface ELISA
assay (Figure 3). Therefore, the upper limit to the decrease in net
BRET one could expect due to internalization is within this range.
In our experiments 25–30% of the net BRET signal between
b2AR-Rluc8 and b2AR D113S-V was lost after stimulation with
isoproterenol, thus we conclude that at least half of the associations
that contribute to BRET at the cell surface can be disrupted by
internalization. This is almost certainly an underestimate, since a
fraction of the BRET signal that we measure prior to agonist
stimulation presumably originates from b2ARs in intracellular
compartments, and would not be expected to change in response
to agonist stimulation. For example, if half of the total BRET
signal originated from intracellular compartments prior to agonist
stimulation, then only 25% of the total BRET signal could be lost
due to internalization of 50% of the receptors originally present on
the plasma membrane. Methods capable of quantifying association
of active and inactive b2ARs specifically in the plasma membrane
will be necessary to make a more precise estimate of the fraction of
interactions that are disrupted by internalization [34].
What is the nature of the interactions that are disrupted by
internalization? When expression of b2AR D113S-V was
increased (with constant expression of b2AR-Rluc8) the net BRET
signal approached a maximum [27]. The standard interpretation
of this finding is that random association favors donor:donor
dimers at low acceptor concentrations, and donor:acceptor dimers
at high acceptor concentration, and a maximum is reached when
all donors are associated with acceptors. This interpretation relies
on the assumption that the transmembrane domains of the b2AR
determine dimer assembly irrespective of binding site mutations or
fused reporter proteins. If this is the case, then our results imply
that internalization disrupts some b2AR dimers where one
protomer is active (b2AR-Rluc8) and the other protomer is
inactive (b2AR D113S-V). We cannot rule out the possibility that
some donor:donor dimers are present even when the acceptor
concentration is very high. In this case some (or all) of the
internalization-sensitive BRET could reflect removal of b2AR-
Rluc8: b2AR-Rluc8 dimers from higher-order oligomers that
contain b2AR D113S-V protomers in close proximity. However,
the fact that BRET50 was not changed after agonist-induced
internalization implies that the average stability of b2AR
associations is the same before and after internalization. The
simplest interpretation of this finding is that internalization
disrupts a fraction of a homogeneous class of interactions,
although more complex scenarios are certainly possible. In either
case, our results are difficult to reconcile with a model wherein
b2ARs randomly form dimers that remain stable during
internalization driven by activation of a single protomer.
The simplest model that accomodates our findings would be
that b2ARs associate with each other transiently, such that there is
a monomer-dimer equilibrium on the cell surface. Recruitment of
active protomers to clathrin-coated pits would lead to passive
secondary recruitment of inactive protomers. However, if b2AR
protomers dissociate at a rate comparable to the rate of
recruitment to coated pits, the ratio of active (wild-type) to
inactive (e.g. binding-defective) protomers would be higher in
coated pits and vesicles than on the unstimulated cell surface. This
would lead to selective internalization of active protomers, the
degree of selectivity being determined by the stability of the
protomer-protomer interaction. This mechanism would be
consistent with the suggestion that some GPCRs associate with
each other only transiently on the cell surface [12,13,14]. We can
not exclude a more complicated scenario that involves a more
active mechanism of protomer segregation. Such an active
mechanism would be necessary if, as has been suggested, b2ARs
form relatively stable oligomers [12].
In summary, we find that the interactions between b2ARs that
produce energy transfer are not entirely stable. Agonist stimulation
leads to internalization of active b2AR protomers, while inactive
protomers remain in the plasma membrane, even if these
protomers were initially in close proximity to one another. These
findings suggest that the impact of GPCR self-association on the
trafficking of individual protomers or dimers may differ depending
on the particular receptor and trafficking step involved.
Materials and Methods
Plasmid DNA constructs
A plasmid encoding Rluc8 [35] was provided by Dr. Sanjiv Sam
Gambhir (Stanford University, Palo Alto, CA). A plasmid
encoding venus-kras was provided by Dr. Stephen R. Ikeda
(NIAAA, Rockville, MD). A plasmid encoding arrestin2 (319–418)
was provided by Dr. Jeffrey L. Benovic (Thomas Jefferson
University, Philadelphia, PA). Fusion proteins were constructed
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QuikChange (Stratagene, La Jolla, CA) mutagenesis protocol.
All constructs were verified by automated sequencing.
Cell culture, transfection, and ligand treatment
HEK 293 cells (ATCC, Manassas, VA) were propagated in
plastic flasks, in 6-well plates and on polylysine-coated glass
coverslips according to the supplier’s protocol. Cells were
transfected in growth medium using linear polyethyleneimine
(MW 25,000; Polysciences Inc., Warrington, PA) at an N/P ratio
of 20; up to 3 mg of plasmid DNA was transfected per well of a 6-
well plate. Cells were used for experiments 16–24 hours after
transfection. Isoproterenol was applied to adherent cells in
complete growth medium and incubated at 37uC (unless otherwise
indicated) and 5% CO2 for 30 minutes. As indicated, prior to
addition of isoproterenol some cells were: supplemented with
50 mM NaHEPES (pH 7) and maintained at 4uC for 15 minutes;
supplemented with 400 mM sucrose for 15 minutes; treated with
either dynasore (80 mM) or vehicle (DMSO) for 30 minutes.
BRET measurements
Cells were detached from plates by rinsing with PBS-EDTA and
triturating in PBS. For time course experiments (Figures 1E and 3B)
cells were washed and suspended in PBS containing 10 mM
propranolol. Suspended cells were transferred to black 96-well
microplates. Coelenterazine h (5 mM; Nanolight Technologies,
Pinetop, AZ) was added to all wells immediately prior to making
measurements. Luminescence measurements were made using a
photon-counting plate reader (Mithras LB940; Berthold Technol-
ogies GmbH, Bad Wildbad, Germany). The raw BRET signal was
calculated as the emission intensity at 520–545 nm divided by the
emission intensity at 475–495 nm. Net BRET was this ratio minus
thesameratiomeasuredfrom cellsexpressing onlytheBRET donor
(Rluc8). Fluorescence intensity was measured prior to addition of
coelenterazine h. Acceptor fluorescence and donor luminescence
were monitored to ensure comparable levels of b2AR expression
unless expression was intentionally varied (Figure 3C).
Confocal imaging
Confocal images (Figure 1) were acquired using a Leica
(Wetzlar, Germany) SP2 scanning confocal microscope and a
63X, 1.4 NA objective. Cerulean and venus were excited with the
458 nm and 514 nm lines of an ArKr laser, and detected at 465–
490 nm 520–550 nm, respectively.
Quantification of cell-surface b2ARs by ELISA
Cells were washed with PBS, then blocked in ice-cold PBA (1%
bovine serum albumin, 0.1% sodium azide in PBS) for 30 minutes.
Cells were incubated in 1:1000 M2 anti-FLAG monoclonal
antibody (Stratagene, La Jolla, CA) in PBA for 30 minutes at room
temperature, washed three times with PBS, then incubated in
1:1000 HRP-conjugated goat anti-mouse secondary antibody
(Jackson ImmunoResearch, West Grove, PA) in PBA for 30
minutes at room temperature. After washing in PBS cells were
detached from plates and distributed into white 96-well plates.
Chemiluminescent substrate (Pierce SuperSignal ELISA Pico,
Thermo Fisher Scientific, Rockford, IL) was added according to
the manufacturer’s instructions. Readings were background-
subtracted using samples exposed only to the secondary antibody.
The average signal/background ratio for control cells was 54610
(n=16). Signals were normalized to cell number, which was
estimated from measurements of FM1-43 fluorescence.
Statistical analysis
Comparisons involving two sets of data were made using either
a paired or unpaired student’s t-test. Comparisons involving more
than two sets of data were made using a repeated measures
ANOVA. Each transient transfection was treated as an individual
subject, and pairing by subjects was significant for both paired t-
tests and repeated measures ANOVA. All data are reported in the
text and figures as mean 6 S.E.M. All experiments were
performed in quadruplicate.
Supporting Information
Figure S1 Internalization segregates active and inactive
b2ARs. A–E, isoproterenol-induced percent change in net BRET
between wt b2AR-Rluc8 and wt b2AR-V (wt/wt), wt b2AR-Rluc8
and b2AR D113S-V (wt/DS), b2AR D113S-Rluc8 and wt b2AR-
V (DS/wt) and b2AR D113S-Rluc8 and b2AR D113S-V (DS/DS)
in the absence (control) and presence of 400 mM sucrose (A;
n=5–6), incubation at 4uC( B; n=3–6), coexpressed arrestin2
(319–418) (C; n=6–7), coexpressed dynamin K44A (D; n=5),
dynasore (80 mM; E; n=3–4); *, P,0.05; **, P,0.005, paired t-
test, meaning the percent change in net BRET in the presence of
sucrose, etc., is significantly different from the control percent
change in net BRET. Values of net BRET are given in Table S4.
(EPS)
Table S1 net BRET between b2AR-Rluc8 or b2AR D113S-
Rluc8 and V-kras (Figure 1C).
(DOC)
Table S2 net BRET between b2AR-Rluc8 and V-kras
(Figure 4).
(DOC)
Table S3 net BRET between b2AR-Rluc8 wild-type (wt)
and binding-defective (DS) mutants and V-kras
(Figure 2A, C).
(DOC)
Table S4 net BRET between b2AR-Rluc8 and b2AR-V
wild-type (wt) and binding-defective (DS) mutants
(Figure 4 and Figure S1).
(DOC)
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